Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: IMARC | PRODUCT CODE: 1378754

Cover Image

PUBLISHER: IMARC | PRODUCT CODE: 1378754

Renal Denervation Systems Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

PUBLISHED:
PAGES: 143 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 2499
PDF & Excel (5 User License)
USD 3499
PDF & Excel (Corporate License)
USD 4499

Add to Cart

Abstract

The global renal denervation systems market size reached US$ 318 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 2,362 Million by 2028, exhibiting a growth rate (CAGR) of 39.7% during 2022-2028.

Renal denervation (RDN) is an interventional procedure that involves a catheter-based ablation of the sympathetic nerves within the renal artery wall. It maximizes nerve disruption, lowers renin secretion, stimulates natriuresis, and improves renal hemodynamics or blood flow. As a result, RDN systems are extensively used to treat refractory hypertension cases wherein optimal therapy cannot provide relief to the patients.

A significant rise in the prevalence of lifestyle diseases, such as hypertension, on account of the increasing number of individuals who smoke and consume alcohol, rising unhealthy dietary patterns, sedentary and hectic lifestyles, and the growing geriatric population represents, one of the key factors strengthening market growth. Apart from this, the advantages associated with the RDN system, such as fast recovery, safety, time efficiency and cost-effectiveness, are acting as another major growth-inducing factor. Furthermore, the escalating demand for minimally invasive (MI) surgery is also contributing to the growth of the market. The introduction of micro-infusion technology, improving healthcare infrastructure, increasing research and development (R&D) activities and the rising number of filings for regulatory approvals of the systems, are also creating a positive influence on the market growth. Although, a decline in the hospital visits and rescheduling of elective health procedures due to the surging cases of the coronavirus disease (COVID-19) have impacted the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global renal denervation systems market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type, product, technology, application and end user.

Breakup by Product Type:

Catheters

Single Electrode Catheter

Multi Electrode Catheter

RF Generator

Nerve Modifying Agents

Breakup by Product:

Symplicity

Vessix (V2)

EnligHTN

Paradise

Iberis

Others

Breakup by Technology:

Ultrasound Ablation

Radiofrequency Ablation

Microinfusion

Breakup by Application:

Hypertension

Cardiac Disorders

Diabetes

Renal Failure

Others

Breakup by End User:

Diagnostic Centers and Hospitals

Ambulatory Care Centers

Others

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Boston Scientific Group, Kona Medical Inc., Medtronic Plc, Mercator MedSystems, ReCor Medical Inc. (Otsuka Holdings Co. Ltd.), Renal Dynamics, St. Jude Medical Inc. (Abbott) and Terumo Corporation.

Key Questions Answered in This Report:

  • How has the global renal denervation systems market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What has been the impact of COVID-19 on the global renal denervation systems market?
  • What is the breakup of the market based on the product type?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global renal denervation systems market and who are the key players?
  • What is the degree of competition in the industry?
Product Code: SR112023A2558

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Renal Denervation Systems Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Catheters
    • 6.1.1 Market Trends
    • 6.1.2 Major Types
      • 6.1.2.1 Single Electrode Catheter
      • 6.1.2.2 Multi Electrode Catheter
    • 6.1.3 Market Forecast
  • 6.2 RF Generator
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Nerve Modifying Agents
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Product

  • 7.1 Symplicity
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Vessix (V2)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 EnligHTN
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Paradise
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Iberis
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Technology

  • 8.1 Ultrasound Ablation
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Radiofrequency Ablation
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Microinfusion
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Hypertension
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Cardiac Disorders
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Diabetes
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Renal Failure
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by End User

  • 10.1 Diagnostic Centers and Hospitals
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Ambulatory Care Centers
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Others
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Boston Scientific Group
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Kona Medical Inc.
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
    • 16.3.3 Medtronic Plc
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
      • 16.3.3.4 SWOT Analysis
    • 16.3.4 Mercator MedSystems
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
    • 16.3.5 ReCor Medical Inc. (Otsuka Holdings Co. Ltd.)
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
    • 16.3.6 Renal Dynamics
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
    • 16.3.7 St. Jude Medical Inc. (Abbott)
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
    • 16.3.8 Terumo Corporation
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
      • 16.3.8.4 SWOT Analysis
Product Code: SR112023A2558

List of Figures

  • Figure 1: Global: Renal Denervation Systems Market: Major Drivers and Challenges
  • Figure 2: Global: Renal Denervation Systems Market: Sales Value (in Million US$), 2017-2022
  • Figure 3: Global: Renal Denervation Systems Market: Breakup by Product Type (in %), 2022
  • Figure 4: Global: Renal Denervation Systems Market: Breakup by Product (in %), 2022
  • Figure 5: Global: Renal Denervation Systems Market: Breakup by Technology (in %), 2022
  • Figure 6: Global: Renal Denervation Systems Market: Breakup by Application (in %), 2022
  • Figure 7: Global: Renal Denervation Systems Market: Breakup by End User (in %), 2022
  • Figure 8: Global: Renal Denervation Systems Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Renal Denervation Systems (Catheters) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Renal Denervation Systems (Catheters) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Renal Denervation Systems (RF Generator) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Renal Denervation Systems (RF Generator) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Renal Denervation Systems (Nerve Modifying Agents) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Renal Denervation Systems (Nerve Modifying Agents) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Renal Denervation Systems (Symplicity) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Renal Denervation Systems (Symplicity) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Renal Denervation Systems (Vessix- V2) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Renal Denervation Systems (Vessix- V2) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Renal Denervation Systems (EnligHTN) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Renal Denervation Systems (EnligHTN) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Renal Denervation Systems (Paradise) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Renal Denervation Systems (Paradise) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Renal Denervation Systems (Iberis) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Renal Denervation Systems (Iberis) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Renal Denervation Systems (Other Product Types) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Renal Denervation Systems (Other Product Types) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Renal Denervation Systems (Ultrasound Ablation) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Renal Denervation Systems (Ultrasound Ablation) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: Renal Denervation Systems (Radiofrequency Ablation) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: Renal Denervation Systems (Radiofrequency Ablation) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Global: Renal Denervation Systems (Microinfusion) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Global: Renal Denervation Systems (Microinfusion) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Global: Renal Denervation Systems (Hypertension) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Global: Renal Denervation Systems (Hypertension) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Global: Renal Denervation Systems (Cardiac Disorders) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Global: Renal Denervation Systems (Cardiac Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Global: Renal Denervation Systems (Diabetes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Global: Renal Denervation Systems (Diabetes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Global: Renal Denervation Systems (Renal Failure) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Global: Renal Denervation Systems (Renal Failure) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Global: Renal Denervation Systems (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Global: Renal Denervation Systems (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Global: Renal Denervation Systems (Diagnostic Centers and Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Global: Renal Denervation Systems (Diagnostic Centers and Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Global: Renal Denervation Systems (Ambulatory Care Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Global: Renal Denervation Systems (Ambulatory Care Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Global: Renal Denervation Systems (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Global: Renal Denervation Systems (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: North America: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: North America: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: United States: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: United States: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Canada: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Canada: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Asia Pacific: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Asia Pacific: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: China: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: China: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Japan: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Japan: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: India: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: India: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: South Korea: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: South Korea: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Australia: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Australia: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Indonesia: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Indonesia: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Others: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Others: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Europe: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Europe: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Germany: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Germany: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: France: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: France: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: United Kingdom: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 79: United Kingdom: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 80: Italy: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 81: Italy: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 82: Spain: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 83: Spain: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 84: Russia: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 85: Russia: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 86: Others: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 87: Others: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 88: Latin America: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 89: Latin America: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 90: Brazil: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 91: Brazil: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 92: Mexico: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 93: Mexico: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 94: Others: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 95: Others: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 96: Middle East and Africa: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 97: Middle East and Africa: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 98: Global: Renal Denervation Systems Industry: SWOT Analysis
  • Figure 99: Global: Renal Denervation Systems Industry: Value Chain Analysis
  • Figure 100: Global: Renal Denervation Systems Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Renal Denervation Systems Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Renal Denervation Systems Market Forecast: Breakup by Product Type (in Million US$), 2023-2028
  • Table 3: Global: Renal Denervation Systems Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 4: Global: Renal Denervation Systems Market Forecast: Breakup by Technology (in Million US$), 2023-2028
  • Table 5: Global: Renal Denervation Systems Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 6: Global: Renal Denervation Systems Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 7: Global: Renal Denervation Systems Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 8: Global: Renal Denervation Systems Market Structure
  • Table 9: Global: Renal Denervation Systems Market: Key Players
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!